Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$295.41
al cierre: Oct 13, 5:37 PM EDT
$297.05
1.640.56%
After hour: 5:37 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
The Cigna Group ha un obiettivo di prezzo di consenso pari a $382.05, stabilito in base alle ultime valutazioni degli analisti di 23. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Barclays y Cantor Fitzgerald il octubre 7, 2025, septiembre 4, 2025 y agosto 26, 2025. Con un obiettivo di prezzo medio di $367.33 tra le Wells Fargo, Barclays y Cantor Fitzgerald, c'è un implicito 23.66% upside per The Cigna Group da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Barclays
Cantor Fitzgerald
Baird
Guggenheim
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Cigna Group
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/07/2025 | 19.17% | Wells Fargo | $340 → $354 | Maintains | Equal-Weight | |||
09/04/2025 | 28.93% | Barclays | $354 → $383 | Maintains | Overweight | |||
08/26/2025 | 22.87% | Cantor Fitzgerald | $365 → $365 | Reiterates | Overweight → Overweight | |||
08/14/2025 | 25.9% | Baird | $362 → $374 | Maintains | Outperform | |||
08/14/2025 | 14.46% | Wells Fargo | $341 → $340 | Maintains | Equal-Weight | |||
08/04/2025 | 17.83% | Guggenheim | $388 → $350 | Maintains | Buy | |||
08/01/2025 | 19.17% | Barclays | $385 → $354 | Maintains | Overweight | |||
06/26/2025 | 24.89% | RBC Capital | $371 → $371 | Reiterates | Outperform → Outperform | |||
06/03/2025 | 24.89% | RBC Capital | $371 → $371 | Reiterates | Outperform → Outperform | |||
06/02/2025 | 29.61% | Barclays | $382 → $385 | Maintains | Overweight | |||
05/23/2025 | 30.62% | Guggenheim | $388 → $388 | Reiterates | Buy → Buy | |||
05/12/2025 | 36.34% | Truist Securities | $385 → $405 | Maintains | Buy | |||
05/06/2025 | 30.62% | Guggenheim | $384 → $388 | Maintains | Buy | |||
05/05/2025 | 29.61% | Raymond James | $360 → $385 | Maintains | Strong Buy | |||
05/05/2025 | 25.9% | Piper Sandler | $348 → $374 | Maintains | Overweight | |||
05/05/2025 | — | Guggenheim | — | Reiterates | Buy → Buy | |||
05/05/2025 | 31.29% | Morgan Stanley | $379 → $390 | Maintains | Overweight | |||
05/05/2025 | 28.6% | Barclays | $339 → $382 | Maintains | Overweight | |||
04/15/2025 | 21.87% | Baird | $388 → $362 | Maintains | Outperform | |||
04/11/2025 | 29.61% | Truist Securities | $375 → $385 | Maintains | Buy | |||
04/09/2025 | 29.27% | Guggenheim | → $384 | Initiates | → Buy | |||
04/09/2025 | 29.27% | Mizuho | — | $360 → $384 | Maintains | Outperform | ||
03/20/2025 | 22.87% | Cantor Fitzgerald | $350 → $365 | Maintains | Overweight | |||
02/04/2025 | 26.24% | Truist Securities | $390 → $375 | Maintains | Buy | |||
02/04/2025 | 14.8% | Wells Fargo | $370 → $341 | Maintains | Equal-Weight | |||
02/03/2025 | 31.29% | UBS | $410 → $390 | Maintains | Buy | |||
02/03/2025 | 17.15% | Piper Sandler | $394 → $348 | Reiterates | Overweight → Overweight | |||
01/31/2025 | 19.51% | RBC Capital | $377 → $355 | Maintains | Outperform | |||
01/31/2025 | 26.24% | Oppenheimer | $400 → $375 | Maintains | Outperform | |||
01/31/2025 | 21.19% | Raymond James | $415 → $360 | Reiterates | Strong Buy → Strong Buy | |||
01/31/2025 | 27.92% | Stephens & Co. | $410 → $380 | Maintains | Overweight | |||
01/31/2025 | 17.83% | Cantor Fitzgerald | $400 → $350 | Maintains | Overweight | |||
01/31/2025 | 27.59% | Morgan Stanley | $403 → $379 | Maintains | Overweight | |||
01/31/2025 | 14.12% | Barclays | $420 → $339 | Maintains | Overweight | |||
01/06/2025 | 31.29% | Truist Securities | $420 → $390 | Maintains | Buy | |||
11/18/2024 | 24.56% | Wells Fargo | $355 → $370 | Maintains | Equal-Weight | |||
11/05/2024 | 32.64% | Piper Sandler | $392 → $394 | Reiterates | Overweight → Overweight | |||
11/05/2024 | 41.39% | Barclays | $405 → $420 | Maintains | Overweight | |||
11/04/2024 | 32.64% | Deutsche Bank | $398 → $394 | Maintains | Buy | |||
11/01/2024 | 38.02% | Stephens & Co. | $410 → $410 | Reiterates | Overweight → Overweight | |||
11/01/2024 | 26.91% | RBC Capital | $384 → $377 | Maintains | Outperform | |||
10/23/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
10/01/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
09/17/2024 | 42.06% | Jefferies | $402 → $422 | Maintains | Buy | |||
09/16/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
09/10/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
09/09/2024 | 29.27% | RBC Capital | $384 → $384 | Reiterates | Outperform → Outperform | |||
08/21/2024 | 47.45% | JP Morgan | $435 → $438 | Maintains | Overweight | |||
08/19/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
08/02/2024 | 38.02% | Stephens & Co. | $410 → $410 | Reiterates | Overweight → Overweight | |||
08/02/2024 | 36.34% | Barclays | $393 → $405 | Maintains | Overweight | |||
07/10/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
06/26/2024 | 34.66% | Piper Sandler | → $400 | Initiates | → Overweight | |||
06/12/2024 | 34.66% | Cantor Fitzgerald | $400 → $400 | Reiterates | Overweight → Overweight | |||
05/30/2024 | 46.44% | JP Morgan | $432 → $435 | Maintains | Overweight | |||
05/30/2024 | 30.62% | Baird | → $388 | Initiates | → Outperform | |||
05/03/2024 | 34.66% | Cantor Fitzgerald | $384 → $400 | Maintains | Overweight | |||
05/03/2024 | 34.66% | Oppenheimer | $370 → $400 | Maintains | Outperform | |||
04/10/2024 | 29.27% | Cantor Fitzgerald | $384 → $384 | Reiterates | Overweight → Overweight | |||
03/08/2024 | 29.27% | Cantor Fitzgerald | $372 → $384 | Maintains | Overweight | |||
03/08/2024 | 34.66% | UBS | $385 → $400 | Maintains | Buy | |||
03/08/2024 | 28.93% | RBC Capital | $354 → $383 | Maintains | Outperform | |||
03/08/2024 | 29.61% | Mizuho | $370 → $385 | Maintains | Buy | |||
03/08/2024 | 34.66% | Truist Securities | $380 → $400 | Reiterates | Buy → Buy | |||
03/06/2024 | 32.3% | Barclays | → $393 | Initiates | → Overweight | |||
03/04/2024 | 25.23% | Cantor Fitzgerald | $372 → $372 | Reiterates | Overweight → Overweight | |||
03/04/2024 | 31.96% | Morgan Stanley | $382 → $392 | Reiterates | Overweight → Overweight | |||
02/06/2024 | 17.15% | Wells Fargo | $334 → $348 | Maintains | Equal-Weight | |||
02/05/2024 | 24.56% | Mizuho | $360 → $370 | Maintains | Buy | |||
02/05/2024 | 25.23% | Cantor Fitzgerald | $334 → $372 | Upgrade | Neutral → Overweight | |||
02/05/2024 | 19.17% | RBC Capital | $327 → $354 | Upgrade | Sector Perform → Outperform | |||
02/01/2024 | 24.56% | Deutsche Bank | $355 → $370 | Upgrade | Hold → Buy | |||
01/19/2024 | 12.44% | Cantor Fitzgerald | $334 → $334 | Reiterates | Neutral → Neutral | |||
01/17/2024 | 21.19% | Oppenheimer | → $360 | Reiterates | Outperform → Outperform | |||
01/04/2024 | 25.23% | Bernstein | → $372 | Upgrade | Market Perform → Outperform | |||
12/12/2023 | 19.51% | Deutsche Bank | $351 → $355 | Maintains | Hold | |||
12/11/2023 | 14.8% | Jefferies | $335 → $341 | Upgrade | Hold → Buy | |||
11/30/2023 | 10.08% | RBC Capital | → $327 | Reiterates | Sector Perform → Sector Perform | |||
11/15/2023 | 10.08% | RBC Capital | → $327 | Reiterates | Sector Perform → Sector Perform | |||
11/03/2023 | 10.08% | RBC Capital | $300 → $327 | Maintains | Sector Perform | |||
11/03/2023 | 12.44% | Cantor Fitzgerald | $310 → $334 | Maintains | Neutral | |||
09/14/2023 | 4.36% | Cantor Fitzgerald | $292 → $310 | Maintains | Neutral | |||
08/18/2023 | — | Edward Jones | — | Downgrade | Buy → Hold | |||
08/07/2023 | 11.09% | Raymond James | $310 → $330 | Maintains | Strong Buy | |||
08/04/2023 | 17.83% | B of A Securities | $320 → $350 | Maintains | Buy | |||
07/13/2023 | 19.51% | UBS | $375 → $355 | Maintains | Buy | |||
07/07/2023 | 14.8% | JP Morgan | $356 → $341 | Maintains | Overweight | |||
06/28/2023 | 16.14% | Stephens & Co. | → $345 | Reiterates | Overweight → Overweight | |||
06/20/2023 | 22.87% | Truist Securities | $375 → $365 | Maintains | Buy | |||
06/06/2023 | 7.73% | B of A Securities | → $320 | Upgrade | Neutral → Buy | |||
05/08/2023 | 4.36% | Deutsche Bank | $384 → $310 | Maintains | Hold | |||
05/08/2023 | -3.38% | RBC Capital | $333 → $287 | Maintains | Sector Perform | |||
05/08/2023 | -4.39% | Wells Fargo | $355 → $284 | Maintains | Equal-Weight | |||
05/08/2023 | 4.36% | Raymond James | $350 → $310 | Maintains | Strong Buy | |||
04/26/2023 | -14.83% | Bernstein | $367 → $253 | Maintains | Market Perform | |||
04/21/2023 | -4.06% | Cantor Fitzgerald | → $285 | Initiates | → Neutral | |||
04/05/2023 | 17.83% | Raymond James | → $350 | Upgrade | Outperform → Strong Buy | |||
03/30/2023 | 21.19% | Mizuho | → $360 | Reiterates | → Buy | |||
03/21/2023 | 24.56% | Stephens & Co. | → $370 | Reiterates | → Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Cigna Group (CI)?
El último precio objetivo de Cigna Group (NYSE:CI) fue comunicado por Wells Fargo el octubre 7, 2025. La firma de analistas fijó un precio objetivo para $354.00 que espera CI a rise dentro de 12 meses (un posible 19.17% upside). 42 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Cigna Group (CI)?
La última calificación de analistas para Cigna Group (NYSE:CI) fue proporcionada por Wells Fargo, y Cigna Group mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Cigna Group (CI)?
La última revisión al alza de The Cigna Group se produjo en febrero 5, 2024, cuando Cantor Fitzgerald elevó su precio objetivo a $372. Cantor Fitzgerald anteriormente tenía a neutral para The Cigna Group.
¿Cuándo fue la última revisión a la baja de Cigna Group (CI)?
La última revisión a la baja de The Cigna Group se produjo en agosto 18, 2023, cuando Edward Jones cambió su precio objetivo de N/A a N/A para The Cigna Group.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Cigna Group (CI)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Cigna Group, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Cigna Group se registró el octubre 7, 2025, por lo que la próxima calificación estará disponible en torno al octubre 7, 2026.
¿Es correcta la calificación de los analistas sobre Cigna Group (CI)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Cigna Group (CI) fue un mantuvo con un precio objetivo de $340.00 a $354.00. El precio actual al que cotiza Cigna Group (CI) es de $297.05, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.